Damian Marron

Damian Marron is currently Chairman at Circio Holding ASA since 2020, Non-Executive Chairman at Cytoseek Ltd., Chairman at Indegra Therapeutics Ltd., Chairman at Onya Therapeutics Ltd., Chairman at Nicox SA since 2024, Director at Cantargia AB since 2021, Director at Loxbridge Research LLP, Director at Agalimmune Ltd., Director at Resolys Bio, Inc. since 2018, and Head-Biopharma at Treehill Partners, LLC.
Former roles include Chief Executive Officer at Cytheris SA, Chief Executive Officer at Trophos SA from 2008 to 2012, Chief Executive Officer & Director at Sangamo Therapeutics France SAS from 2013 to 2015, Chairman at PepGen Ltd., Non-Executive Chairman at Imophoron Ltd., Director at France Biotech Association, Independent Non-Executive Director at Bone Therapeutics SA, Director at Theralpha, Executive Vice President-Corporate Development at Nicox SA from 2002 to 2008, Manager-Drug Group at Orphan Europe SARL, Head-European Development Business at Bausch & Lomb (Australia) Pty Ltd. in 2013, Principal at Rhone-Poulenc Rorer BV from 1991 to 2013, and Principal at Glaxo Wellcome Immobilière de Recherche SA from 1986 to 2013.
Education includes an undergraduate degree from The University of Liverpool, conferred in 1985.